Anna Foged Thomsen

MD, PhD, Cardiologist fellow | Special interest in EP Imaging and VT | 100% runner | Co-founder of @RigsHeart🫀

[Anna Foged Thomsen @anna_foged]

Happy to announce that I yesterday earned my PhD🎓🫀

Thank you all for making this an adventurous journey!

A warm thanks to my supervisors Peter Karl Jacobsen, Christian Jøns and Lars Køber & the assessment committee @JacobTfelt @EHRAPresident and Jens Cosedis - an honour😊

[JB Guichard_EP @guichard_jb]

Fast or slow VT? It’s all about the isthmus. ⚡🐌

Our work revisits the relationship between substrate and VT rate, demonstrating that conduction isthmus structure and function outperform global scar burden in predicting fast ventricular tachycardia.

@ivroca

[Anna Foged Thomsen @anna_foged]

https://t.co/hSgyhqq9dd

[Anna Foged Thomsen @anna_foged]

Scar border zone characteristics are key in post-MI arrhythmogenesis.

Our CMR study on border zone mass & channels after STEMI is now referenced in Braunwald’s ACS companion.

Adds to risk stratification beyond LVEF.

#CardioTwitter #EP #CMR

[Anna Foged Thomsen @anna_foged]

https://t.co/cFhX4Th00t

[Ivo Roca, FEHRA, FESC @ivroca]

Recently published in @CircAHA our long-term PAM-VT2 study: Post-ablation MRI to predict long-term VT recurrence, to assess scar evolution, new +remodelling effect after ablation proved! A long journey working together EP, imaging, bioengineers. https://t.co/frY1ugnr1U

[Anna Foged Thomsen @anna_foged]

@JohannaKroell Ouch - LV apical thrombus secondary to severe systolic dysfunction

[NEJM @NEJM]

Presented at #ESCCongress:

In patients with cardiovascular disease and an implantable cardioverter–defibrillator, increasing potassium levels to the high-normal range reduced the risk of arrhythmia events, hospitalizations, and death. Full POTCAST trial results: https://t.co/NCnp8gaUoB

@escardio

[CTCPR Trials & CIRL @CTCPR_]

🫀 New discovery @CTCPR_ study by @fwemmer1 & colleagues: Territorial myocardial work detects coronary artery calcium in chronic kidney disease patients — a breakthrough for diagnosing coronary artery disease in this challenging group!
Explore further https://t.co/XvOdlpbTUQ

[European Society of Cardiology Journals @ESC_Journals]

You have survived cardiac arrest - but what's next? Check this TOMAHAWK substudy on quality of life
♀️showed ⬆️anxiety/depression, ⬇️ usual activities and self-care in FU.
Post- cardiac arrest care is a long-term process #EHJACVC https://t.co/geatYub06x

@EHJACVCEiC @JaninePoss @CHassager @AnneFreund3 @ACVCPresident @drmilicaa @ann_oleksiak @maria_bergami

[JICE @JICE_EP]

🚨Latest #FreeRead Article in
@JICE_EP

Left Atrial Wall Thickness Correlates with PV Reconnection following Atrial Fibrillation Ablation

🧐📖 https://t.co/Vop8lNzom0

by @AlexK_EP, @CRB_EP, @ExtraStim, Douglas Holmes, Anthony Aizer, David Park, Scott Bernstein, Michael A. Spinelli, Leonid Garber, @FYang_EP, Elizabeth Rosinski & @lchinitz1

#EPeeps

[JICE @JICE_EP]

🚨New #OpenAccess Article in
@JICE_EP

Head-to-Head Comparison of PFA, HPSD Ablation, Cryoballoon and Conventional RF Ablation by MRI-based Ablation Lesion Assessment

🧐📖 https://t.co/cmP9gVbmOA

by Mariona Regany-Closa, Josep Pomes-Perez, Eric Invers-Rubio, Roger Borras, Berta Pellicer-Sendra, Susanna Prat-Gonzalez, Rosario Jesus Perea, Carlos Igor Morr, Jean-Baptiste Guichard, Elena Arbelo, @tolosanaviu, @EduGuasch, @aportasanchez, Marta Sitges, @BrugadaJosep,@ivroca, @LluisMont2 & @TillAlthoff

#EPeeps

[EHRAPresident @EHRAPresident]

#EHRAtopicweek on SCD in HF

SCD risk in HF: Are we missing patients?

📉 Current ICD eligibility hinges on LVEF ≤35%
⚠️ But many SCDs strike above that threshold
📚 SCD-HeFT backed ICDs in both ischemic & non-ischemic HF
🤔 DANISH trial challenged the benefit in non-ischemic HF

➡️ Is it time to rethink risk stratification?

@escardio

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update: @JACCJournals

🥸Commentary on the guidelines - early beta blocker use post MI -

😱@MichaelGNanna wrote extensively on this in older pts.

🥸Take a look

👇👇👇

[JICE @JICE_EP]

🚨Latest #FreeRead Article in
@JICE_EP

The Use of Cardiac Imaging in Patients Undergoing Atrial Fibrillation Ablation

🧐📖https://t.co/cXynKxeyr4

by @filiberti_gaia, Giulia Antonelli, @DrFalasconi, @AleVillaschi, @Figliozzis, @MartinaMariaRu1, Antonio Taormina, @GuidoDelMonaco9, @ACLatini, Sebastiano Carli, Kamil Stankowski, Stefano Valcher, Nicola Cesani, Francesco Amata, Alessandro Giaj Levra, Filippo Giunti, Giacomo Carella, @Davidsotoiglesi, @dariorici, @FedericoLandra1, @AndreaSaglietto, Emanuele Curti, @pietro_francia, @AlmorJulio @DrBerruezo

#EPeeps

[Circulation @CircAHA]

#ICYMI: Cardiovascular Risks in Anabolic Steroid Users @TorBiering @fwemmer1

[Anna Foged Thomsen @anna_foged]

https://t.co/odc7gyRgRb

[Anna Foged Thomsen @anna_foged]

🫀my first PhD article - our #CARISMA sub study on the risk of #arrhythmias after #ACS according to mode of #revascularization - has made it to the new 2025 ACC/AHA guideline for the management of #ACS 👇

[Circulation @CircAHA]

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes #AHAJournals
https://t.co/b2zBvftuZI

[Anna Foged Thomsen @anna_foged]

https://t.co/odc7gyRgRb

[American College of Cardiology @ACCinTouch]

Patients with a history of #CVD, compared with those without, had a higher incidence of sudden cardiac death, according to a study of 5.5 million Danish citizens in 2010.

Read more: https://t.co/XXslVIeh51 #JACCCEP

[Tobias Skjelbred @TobiasSkjelbred]

New study in JACC: Clinical EP! We found that 45% of sudden cardiac deaths occur in individuals with no prior cardiovascular diagnosis.
Read here:
https://t.co/wNnwEZCB4Q

@JacobTfelt @bowinkel75 @RigsHeart